Genpact LTD
- Last sale
- Nov 12, 2026 · -1.09%
- Market cap
- $7.21B
- 167.23M shares
- Filings
- 1,049
Q3 2026+6.6% FY25 yoy
Q3 2026+7.6% FY25 yoy
Q3 2026+6.9% FY25 yoy
Q3 2026derived+37.9% FY25 yoy
Q3 2026+9.8% FY25 yoy
Q3 2026+31.7% FY25 yoy
- $7.21B
- 12.3×
- 1.3×
- 2.7×
- 4.94%
- 1.72%
Twelve months to Sep 30, 2026 · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $5,079,879,000 | reported | |
| FY 2024 | 2024-12-31 | $4,767,139,000 | reported | |
| FY 2023 | 2023-12-31 | $4,476,888,000 | reported | |
| FY 2022 | 2022-12-31 | $4,371,172,000 | reported | |
| FY 2021 | 2021-12-31 | $4,022,211,000 | reported | |
| FY 2020 | 2020-12-31 | $3,709,377,000 | reported | |
| FY 2019 | 2019-12-31 | $3,520,543,000 | reported | |
| FY 2018 | 2018-12-31 | $3,000,790,000 | reported | |
| FY 2017 | 2017-12-31 | $2,736,929,000 | reported | |
| FY 2016 | 2016-12-31 | $2,570,756,000 | reported | |
| FY 2014 | 2014-12-31 | $2,279,438,000 | reported | |
| FY 2013 | 2013-12-31 | $2,131,997,000 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2025 | $117.75M | — | $117.75M | $0.68 | 169.86M sh | −3.3% | 16.0% |
| FY2024 | $108.47M | $252.67M | $361.14M | $0.61 | 175.67M sh | −2.8% | 67.8% |
| FY2023 | $100.01M | $225.50M | $325.51M | $0.55 | 180.73M sh | −1.8% | 74.8% |
| FY2022 | $91.84M | $214.08M | $305.92M | $0.50 | 183.98M sh | −0.6% | 77.8% |
| FY2021 | $80.48M | $298.22M | $378.70M | $0.43 | 185.17M sh | −1.6% | 59.1% |
Segments
LineFY2025ShareChange
High Tech and Manufacturing$2.00B39%+11.9%
Consumer and Healthcare$1.72B34%+1.9%
Financial Services$1.36B27%+5.3%
BCMI———
CGRLH———
HMS———
Total$5.08B
Management consulting services
Genpact LTD is the 2nd largest of the 60 covered companies the SEC files under this code, by revenue. SIC 8742
CompanyRevenueGrowthNet marginMarket cap
BAHBooz Allen Hamilton Holding Corp$11.2B6.4%7.6%$10.3B
GGenpact LTD (this company)$5.1B6.6%10.9%$7.2B
FCNFTI Consulting, Inc$3.8B2.4%7.1%$5.4BASTHAstrana Health, Inc.$3.2B56.4%0.7%$1.8BICFIICF International, Inc.$1.9B7.3%4.9%$1.5BHURNHuron Consulting Group Inc.$1.7B11.7%6.2%$2.6BONTOnterris, Inc.$830.5M19.3%0.1%$812.0MEXPOExponent Inc$582.0M4.2%18.2%$4.1BBWMNBowman Consulting Group Ltd.$490.0M14.9%2.6%$754.2MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Genpact LTD · CIK 1398659 · Engraved from SEC EDGAR